Review article: Acidity and volume of the refluxate in the genesis of gastro-oesophageal reflux disease symptoms

Alimentary Pharmacology and Therapeutics

Volumn 25, Issue 9, 2007, Pages 1003-1017

  Sifrim, D ^a   Mittal, R ^b   Fass, R ^c   Smout, A ^d   Castell, D ^e   Tack, J ^a   Gregersen, H ^f  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; PEPSIN A; PLACEBO; PROTON PUMP INHIBITOR; TRYPSIN;

BILE; CHEMORECEPTOR; CLINICAL TRIAL; COUGHING; DISEASE ACTIVITY; DISEASE MARKER; DROWSINESS; DRUG TREATMENT FAILURE; ECHOGRAPHY; ENDOSCOPY; ESOPHAGUS DISEASE; ESOPHAGUS MUSCLE; FOOD; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL REFLUX; GASTROINTESTINAL SYMPTOM; HEARTBURN; HUMAN; MECHANORECEPTOR; MEDICAL SPECIALIST; MUSCLE CONTRACTION; NAUSEA; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; REVIEW; STOMACH ACID; STOMACH FUNDOPLICATION; STOMACH PH; THORAX PAIN; TREATMENT RESPONSE;

EID: 34247115102     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2007.03281.x     Document Type: Review

References (76)

1. Dean BB, Gano AD Jr, Knight K, et al. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol 2004; 2: 656-64.
2. Barlow WJ, Orlando RC. The pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis. Gastroenterology 2005; 128: 771-8.
3. Smith JL, Opekun AR, Larkai E, et al. Sensitivity of the esophageal mucosa to pH in gastroesophageal reflux disease. Gastroenterology 1989; 96: 683-9.
4. Weusten BLAM, Smout AJPM. Ambulatory monitoring of esophageal pH and pressure. In: Castell DO, Richter JE, eds. The Esophagus. Philadelphia: Lippincott Williams & Wilkins, 2004: 135-50.
5. Martinez SD, Malagon IB, Garewal HS, et al. Non-erosive reflux disease (NERD) - acid reflux and symptom patterns. Aliment Pharmacol Ther 2003; 17: 537-45.
6. Jung B, Steinbach J, Beaumont C, et al. Lack of association between esophageal acid sensitivity detected by prolonged pH monitoring and Bernstein testing. Am J Gastroenterol 2004; 99: 410-5.
7. Lenglinger J, Eisler M, Riegler M. NERD and 'GERD without burn': no more a miracle. Gastroenterology 2005; 129: 396; author reply 396-7.
8. Fass R, Tougas G. Functional heartburn: the stimulus, the pain, and the brain. Gut 2002; 51: 885-92.
9. Wiener GJ, Richter JE, Copper JB, et al. The Symptom Index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol 1988; 83: 358-61.
10. Breumelhof R, Smout AJ. The Symptom Sensitivity Index: a valuable additional parameter in 24-hour esophageal pH recording. Am J Gastroenterol 1991; 86: 160-4.
11. Ghillebert G, Janssens J, Vantrappen G, et al. Ambulatory 24 h intraoesophageal pH and pressure recordings v provocation tests in the diagnosis of chest pain of oesophageal origin. Gut 1990; 31: 738-44.
12. Weusten BL, Roelofs JM, Akkermans LM, et al. The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology 1994; 107: 1741-5.
13. Lam HG, Breumelhof R, Roelofs JM, et al. What is the optimal time window in symptom analysis of 24-hour esophageal pressure and pH data? Dig Dis Sci 1994; 39: 402-9.
14. Taghavi SA, Ghasedi M, Saberi-Firoozi M, et al. Symptom association probability and symptom sensitivity index: preferable but still suboptimal predictors of response to high dose omeprazole. Gut 2005; 54: 1067-71.
15. Watson RG, Tham TC, Johnston BT, et al. Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux - the 'sensitive oesophagus'. Gut 1997; 40: 587-90.
16. Prakash C, Clouse RE. Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2005; 3: 329-34.
17. Bredenoord AJ, Weusten BL, Timmer R, et al. Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy. Am J Gastroenterol 2006; 101: 453-9.
18. Zerbib F, Roman S, Ropert A, et al. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol 2006; 101: 1956-63.
19. Mainie I, Tutuian R, Shay S, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy. A multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006; 55: 1398-402.
20. Mainie I, Tutuian R, Hila A, et al. Symptom type on PPI therapy does not predict reflux identified by MII-pH. Gastroenterology 2006; 130: A630 (abstract).
21. Wunderlich AW, Murray JA. Temporal correlation between chronic cough and gastroesophageal reflux disease. Dig Dis Sci 2003; 48: 1050-6.
22. Sifrim D, Dupont L, Blondeau K, et al. Weakly acidic reflux in patients with chronic unexplained cough during 24 h pressure, pH, and impedance monitoring. Gut 2005; 54: 449-54.
23. Holzer P. Acid-sensitive ion channels in gastrointestinal function. Curr Opin Pharmacol 2003; 3: 618-25.
24. Matthews PJ, Aziz Q, Facer P, et al. Increased capsaicin receptor TRPV1 nerve fibres in the inflamed human oesophagus. Eur J Gastroenterol Hepatol 2004; 16: 897-902.
25. Geppetti P, Trevisani M. Activation and sensitisation of the vanilloid receptor: role in gastrointestinal inflammation and function. Br J Pharmacol 2004; 141: 1313-20.
26. Waldmann R, Champigny G, Bassilana F, et al. A proton-gated cation channel involved in acid-sensing. Nature 1997; 386: 173-7.
27. Page AJ, Brierley SM, Martin CM, et al. The ion channel ASIC1 contributes to visceral but not cutaneous mechanoreceptor function. Gastroenterology 2004; 127: 1739-47.
28. Waldmann R, Champigny G, Lingueglia E, et al. H(+)-gated cation channels. Ann N Y Acad Sci 1999; 868: 67-76.
29. Siddiqui A, Rodriguez-Stanley S, Zubaidi S, et al. Esophageal visceral sensitivity to bile salts in patients with functional heartburn and in healthy control subjects. Dig Dis Sci 2005; 50: 81-5.
30. Vaezi MF, Richter JE. Synergism of acid and duodenogastroesophageal reflux in complicated Barrett's esophagus. Surgery 1995; 117: 699-704.
31. Page AJ, Martin CM, Blackshaw LA. Vagal mechanoreceptors and chemoreceptors in mouse stomach and esophagus. J Neurophysiol 2002; 87: 2095-103.
32. Weusten BL, Smout AJ. Analysis of 24-h oesophageal pH and pressure recordings. Eur J Gastroenterol Hepatol 1995; 7: 1147-51.
33. Weusten BL, Akkermans LM, vanBerge-Henegouwen GP, et al. Symptom perception in gastroesophageal reflux disease is dependent on spatiotemporal reflux characteristics. Gastroenterology 1995; 108: 1739-44.
34. Weusten BL, Akkermans LM, vanBerge-Henegouwen GP, et al. Spatiotemporal characteristics of physiological gastroesophageal reflux. Am J Physiol 1994; 266: G357-62.
35. Weusten BL, Akkermans LM, vanBerge-Henegouwen GP, et al. Dynamic characteristic of gastro-oesophageal reflux in ambulatory patients with gastro-oesophageal reflux disease and normal control subjects. Scand J Gastroenterol 1995; 30: 731-7.
36. Cicala M, Emerenziani S, Caviglia R, et al. Intra-oesophageal distribution and perception of acid reflux in patients with non-erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2003; 18: 605-13.
37. Cicala M, Gabbrielli A, Emerenziani S, et al. Effect of endoscopic augmentation of the lower oesophageal sphincter (Gatekeeper reflux repair system) on intraoesophageal dynamic characteristics of acid reflux. Gut 2005; 54: 183-6.
38. Emerenziani S, Cicala M, Zhang X, et al. Measuring proximal gastroesophageal reflux: head to head comparison between multiple pH and multiple impedance. Gastroenterology 2005; 128: A1790 (abstract).
39. Bredenoord AJ, Weusten BL, Curvers WL, et al. Determinants of perception of heartburn and regurgitation. Gut 2006; 55: 313-8.
40. Emerenziani S, Zhang X, Blondeau K, et al. Gastric fullness, physical activity, and proximal extent of gastroesophageal reflux. Am J Gastroenterol 2005; 100: 1251-6.
41. Sifrim D. Relevance of volume and proximal extent of reflux in gastrooesophageal reflux disease. Gut 2005; 54: 175-8.
42. Stein HJ, Feussner H, Kauer W, et al. Alkaline gastroesophageal reflux: assessment by ambulatory esophageal aspiration and pH monitoring. Am J Surg 1994; 167: 163-8.
43. Stipa F, Stein HJ, Feussner H, et al. Assessment of non-acid esophageal reflux: comparison between long-term reflux aspiration test and fiberoptic bilirubin monitoring. Dis Esophagus 1997; 10: 24-8.
44. Kauer WK, Peters JH, DeMeester TR, et al. Composition and concentration of bile acid reflux into the esophagus of patients with gastroesophageal reflux disease. Surgery 1997; 122: 874-81.
45. Mittal RK, Reuben A, Whitney JO, et al. Do bile acids reflux into the esophagus? A study in normal subjects and patients with gastroesophageal reflux disease. Gastroenterology 1987; 92: 371-5.
46. Nehra D, Watt P, Pye JK, et al. Automated oesophageal reflux sampler - a new device used to monitor bile acid reflux in patients with gastro-oesophageal reflux disease. J Med Eng Technol 1997; 21: 1-9.
47. Fisher RS, Malmud LS, Roberts GS, et al. Gastroesophageal (GE) scintiscanning to detect and quantitate GE reflux. Gastroenterology 1976; 70: 301-8.
48. Rhee PL, Liu J, Puckett JL, et al. Measuring esophageal distension by highfrequency intraluminal ultrasound probe. Am J Physiol Gastrointest Liver Physiol 2002; 283: G886-92.
49. Tipnis NA, Liu JM, Mittal RK. Effect of acid inhibition on gastroesophageal reflux induced esophageal distension. Gastroenterology 2005; 128: A529 (abstract).
50. Pratha VS, Hogan DL, Lane JR, et al. Inhibition of pentagastrin-stimulated gastric acid secretion by pantoprazole and omeprazole in healthy adults. Dig Dis Sci. 2006; 51: 123-31.
51. Barish CF, Castell DO, Richter JE. Graded esophageal balloon distention. A new provocative test for noncardiac chest pain. Dig Dis Sci 1986; 31: 1292-8.
52. Deschner WK, Maher KA, Cattau EL Jr, et al. Intraesophageal balloon distention vs. drug provocation in the evaluation of noncardiac chest pain. Am J Gastroenterol 1990; 85: 938-43.
53. Whitehead WE, Delvaux M. Standardization of barostat procedures for testing smooth muscle tone and sensory thresholds in the gastrointestinal tract. The Working Team of Glaxo-Wellcome Research, UK. Dig Dis Sci 1997; 42: 223-41.
54. Fass R, Naliboff B, Higa L, et al. Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans. Gastroenterology 1998; 115: 1363-73.
55. Drews AM, Reddy H, Staal C et al., Sensory-motor responses to mechanical stimulation of the esophagus after sensitization with acid. World J Gastroenterol 2005; 11: 4367-74.
56. Janssens J, Valembois P, Hellemans J, et al. Studies on the necessity of a bolus for the progression of secondary peristalsis in the canine esophagus. Gastroenterology 1974; 67: 245-51.
57. Janssens J, Valembois P, Vantrappen G, et al. Is the primary peristaltic contraction of the canine esophagus bolusdependent? Gastroenterology 1973; 65: 750-6.
58. Takeda T, Liu JM, Gui A, Kassab G, Mittal RK. Heartburn not chest pain, is the most common symptoms in response to esophageal distension in normal subjects. Gastroenterology 2001; 120: A222-3.
59. Takeda T, Nabae T, Kassab G, et al. Oesophageal wall stretch: the stimulus for distension induced oesophageal sensation. Neurogastroenterol Motil 2004; 16: 721-8.
60. Fass R. Sensory testing of the esophagus. J Clin Gastroenterol 2004; 38: 628-41.
61. Balaban DH, Yamamoto Y, Liu J, et al. Sustained esophageal contraction: a marker of esophageal chest pain identified by intraluminal ultrasonography. Gastroenterology 1999; 116: 29-37.
62. Pehlivanov N, Liu J, Mittal RK. Sustained esophageal contraction: a motor correlate of heartburn symptom. Am J Physiol Gastrointest Liver Physiol 2001; 281: G743-51.
63. Bhalla V, Liu J, Puckett JL, et al. Symptom hypersensitivity to acid infusion is associated with hypersensitivity of esophageal contractility. Am J Physiol Gastrointest Liver Physiol 2004; 287: G65-71.
64. Gregersen H. Biomechanics of the Gastrointestinal Tract. London: Springer Verlag, 2002.
65. Drewes AM, Reddy H, Pedersen J, et al. Multimodal pain stimulations in patients with grade B oesophagitis. Gut 2006; 55: 926-32.
66. Drewes AM, Schipper KP, Dimcevski G, et al. Multimodal assessment of pain in the esophagus: a new experimental model. Am J Physiol Gastrointest Liver Physiol 2002; 283: G95-103.
67. Pedersen J, Reddy H, Funch-Jensen P, et al. Differences between male and female responses to painful thermal and mechanical stimulation of the human esophagus. Dig Dis Sci 2004; 49: 1065-74.
68. Tutuian R, Mainie I, Agrawal A, et al. Nonacid reflux in patients with chronic cough on acid-suppressive therapy. Chest 2006; 130: 386-91.
69. Mainie I, Tutuian R, Agrawal A, et al. Combined multichannel impedance-pH identifies patients with persistent reflux symptoms on acid suppression therapy who benefit from laparoscopic Nissen fundoplication. Br J Surg 2006; 93: 1483-7.
70. Zhang X, Tack J, Janssens J, et al. Acid and non-acid gastroesophageal reflux after endoscopic gastroplication. Evaluation of the antireflux barrier function with 24hs-pH-impedance. Gastroenterology 2003; 124: A97 (abstract).
71. Zhang Q, Lehmann A, Rigda R, et al. Control of transient lower oesophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux disease. Gut 2002; 50: 19-24.
72. Lidums I, Lehmann A, Checklin H, et al. Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects. Gastroenterology 2000; 118: 7-13.
73. Ciccaglione AF, Marzio L. Effect of acute and chronic administration of the GABA B agonist baclofen on 24 h pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease. Gut 2003; 52: 464-70.
74. Vela MF, Tutuian R, Katz PO, et al. Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH. Aliment Pharmacol Ther 2003; 17: 243-51.
75. Sifrim D, Tack J, Arts J, et al. Baclofen reduces weakly acidic reflux in ambulant patients with GERD. Gastroenterology 2005; 128: A531 (abstract).
76. Koek GH, Sifrim D, Lerut T, et al. Effect of the GABA(B) agonist baclofen in patients with symptoms and duodenogastro-oesophageal reflux refractory to proton pump inhibitors. Gut 2003; 52: 1397-402.